ETF Holdings Breakdown of GILD

News associated with GILD

After-Hours Earnings Report for April 24, 2025 : GOOGL, GOOG, TMUS, GILD, INTC, RSG, AEM, DLR, HIG, ERIE, SSNC, WY

The following companies are expected to report earnings after hours on 04/24/2025. Visit our Earnings Calendar for a full list of expected earnings releases.Alphabet Inc. (GOOGL)is reporting for the quarter ending March 31, 2025. The internet services company's consensus earning - 2025-04-24 18:00:01

Gilead Sciences (NASDAQ:GILD) vs. 4D Molecular Therapeutics (NASDAQ:FDMT) Critical Contrast

Gilead Sciences (NASDAQ:GILD – Get Free Report) and 4D Molecular Therapeutics (NASDAQ:FDMT – Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation. Analyst Recommendations This is a breakdown of […] - 2025-04-24 05:44:53

XTX Topco Ltd Reduces Stake in Gilead Sciences, Inc. (NASDAQ:GILD)

XTX Topco Ltd cut its holdings in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 25.2% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 5,180 shares of the biopharmaceutical company’s stock after selling 1,744 shares during the period. XTX Topco Ltd’s holdings in […] - 2025-04-21 08:12:59

Nasdaq 100 Movers: GILD, NFLX

In early trading on Tuesday, shares of Netflix topped the list of the day's best performing components of the Nasdaq 100 index, trading up 3.4%. Year to date, Netflix registers a 8.0% gain. And the worst performing Nasdaq 100 component thus far on the day is Gilead Sciences, - 2025-04-15 14:25:21

5,658 Shares in Gilead Sciences, Inc. (NASDAQ:GILD) Acquired by Trexquant Investment LP

Trexquant Investment LP bought a new stake in shares of Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) in the 4th quarter, HoldingsChannel reports. The firm bought 5,658 shares of the biopharmaceutical company’s stock, valued at approximately $523,000. Other hedge funds and other institutional investors have also bought and sold shares of the company. Southland Equity […] - 2025-04-13 09:00:57

Arrowstreet Capital Limited Partnership Sells 2,857,063 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)

Arrowstreet Capital Limited Partnership cut its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 95.3% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 139,606 shares of the biopharmaceutical company’s stock after selling 2,857,063 shares during the quarter. Arrowstreet Capital Limited Partnership’s […] - 2025-04-06 08:26:56

QLD, TXN, GILD, PDD: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra QQQ (Symbol: QLD) where we have detected an approximate $621.9 million dollar inflow -- that's a 10.5% increase week over week in out - 2025-03-20 15:37:07

Company News for Mar 20, 2025

Companies In The Article Are:TSLA, GIS, GILD, HQY - 2025-03-20 12:47:00

Morgan Stanley Boosts Gilead Sciences (NASDAQ:GILD) Price Target to $130.00

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price target hoisted by equities researchers at Morgan Stanley from $123.00 to $130.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price would indicate a potential upside of 14.05% […] - 2025-03-13 06:41:05

After Hours Most Active for Mar 10, 2025 : ACI, NVDA, MRK, AAPL, MSFT, INTC, GILD, JNPR, CX, HOOD, BAC, PM

The NASDAQ 100 After Hours Indicator is down -10.14 to 19,420.81. The total After hours volume is currently 81,053,673 shares traded.The following are the most active stocks for the after hours session: Albertsons Companies, Inc. (ACI) is unchanged at $21.15, with 16,592,965 sha - 2025-03-10 20:06:06

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $140.00 at Wells Fargo & Company

Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price upped by Wells Fargo & Company from $120.00 to $140.00 in a research report issued on Wednesday,Benzinga reports. The firm presently has an “overweight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price objective would indicate a potential upside of 20.65% from […] - 2025-03-07 08:18:48

After Hours Most Active for Mar 5, 2025 : ALTM, NVDA, ENTG, AAPL, GILD, MRVL, PINS, BKD, WMB, XEL, KO, T

The NASDAQ 100 After Hours Indicator is down -66.75 to 20,561.72. The total After hours volume is currently 187,038,432 shares traded.The following are the most active stocks for the after hours session: Arcadium Lithium plc (ALTM) is unchanged at $5.84, with 18,532,384 shares t - 2025-03-05 21:24:56

Oppenheimer Issues Positive Forecast for Gilead Sciences (NASDAQ:GILD) Stock Price

Gilead Sciences (NASDAQ:GILD – Free Report) had its price target raised by Oppenheimer from $115.00 to $132.00 in a report released on Tuesday, Marketbeat reports. Oppenheimer currently has an outperform rating on the biopharmaceutical company’s stock. A number of other research analysts also recently issued reports on the company. JPMorgan Chase & Co. lifted their […] - 2025-03-05 08:58:48

Brokerages Set Gilead Sciences, Inc. (NASDAQ:GILD) PT at $102.08

Gilead Sciences, Inc. (NASDAQ:GILD – Get Free Report) has earned an average rating of “Moderate Buy” from the twenty-nine ratings firms that are presently covering the company, MarketBeat Ratings reports. Eleven research analysts have rated the stock with a hold rating, fifteen have given a buy rating and three have assigned a strong buy rating […] - 2025-03-03 06:50:57

Gilead's Lenacapavir For HIV Prevention Gets Fast-Track Review From European Regulators

(RTTNews) - Gilead Sciences, Inc. (GILD) Monday announced that the European Medicines Agency has validated its applications for accelerated review of lenacapavir, a twice-yearly injectable HIV-1 capsid inhibitor for HIV prevention. - 2025-02-24 16:48:14

GILD Crosses Above Average Analyst Target

In recent trading, shares of Gilead Sciences Inc (Symbol: GILD) have crossed above the average analyst 12-month target price of $101.00, changing hands for $103.31/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade o - 2025-02-13 12:51:03

Why Gilead Sciences is a Top 25 Dividend Giant (GILD)

Gilead Sciences Inc (Symbol: GILD) has been named as a Top 25 ''Dividend Giant'' by ETF Channel, with a stunning $22.93B worth of stock held by ETFs, and above-average ''DividendRank'' statistics including a strong 3.06% yield, according to the most recent Dividend Channel ''Div - 2025-02-13 12:50:26

Gilead Sciences, Inc. (NASDAQ:GILD) Holdings Decreased by U.S. Capital Wealth Advisors LLC

U.S. Capital Wealth Advisors LLC lessened its stake in Gilead Sciences, Inc. (NASDAQ:GILD – Free Report) by 90.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 6,705 shares of the biopharmaceutical company’s stock after selling 64,693 shares during the period. U.S. Capital Wealth […] - 2025-02-06 08:50:54

QLD, TXN, BKNG, GILD: ETF Inflow Alert

Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the ProShares Ultra QQQ (Symbol: QLD) where we have detected an approximate $837.2 million dollar inflow -- that's a 11.4% increase week over week in out - 2025-01-27 16:00:52

GILD institutional holdings

Fatal error: Uncaught mysqli_sql_exception: Column 'Currency_Code' in field list is ambiguous in /var/www/liquidata/show_aggregate_holdings.php:119 Stack trace: #0 /var/www/liquidata/show_aggregate_holdings.php(119): mysqli->query() #1 {main} thrown in /var/www/liquidata/show_aggregate_holdings.php on line 119

Date	ETF ISIN/Name	Num Shares	Book value